Nature Portfolio
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Nature Portfolio
May 7, 2024, 05:04 |
Blog
Aruni Ghose: United Kingdom’s First Real World Evidence of Sacituzumab Govitecan in mTNBC
Aruni Ghose, Editorial Board Member at BMC, shared a post on LinkedIn: "My favourite Registrar Mentor…
May 6, 2024, 10:27 |
Insight
Key features of immune B cells making them successful at targeting tumours - The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn: “NEWS: Scientists have discovered the key…
Apr 22, 2024, 16:05 |
Blog
Steffen Fuchs: The abstract submission is open for the 2nd Young Scientist Cancer Congress
Steffen Fuchs, Postdoctoral Researcher at Cancer Research Center of Toulouse, shared a post on LinkedIn:…
Apr 20, 2024, 06:08 |
Insight
David Planchard: Some advances for our BRAF V600E NSCLC patients…Review to read at npj Journals
David Planchard, Professor at the University of Paris-Saclay, posted on X/Twitter: "Some advances for our BRAF…
Apr 19, 2024, 07:12 |
Insight
Patrick Hwu: Moffitt's Doratha “Armen” Byrd joined me to discuss a recent study in Nature Portfolio and the role of the microbiome in colorectal cancer
Patrick Hwu, President and CEO at Moffit Cancer Center, shared on LinkedIn: “Are specific bacteria…
Apr 12, 2024, 11:25 |
Insight
A Paper in Nature Genetics identifies 41 cell subtypes and highlights age and parity-dependent effects in analysis of over 800.000 human adult breast cells - Nature Portfolio
Mar 10, 2024, 12:24 |
Blog
Vivek Subbiah: Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer
Vivek Subbiah shared a post on X/Twitter: “Hot off the press presenting to the Nature…
Feb 18, 2024, 14:31 |
Blog
Vivek Subbiah: Is this the future?
Vivek Subbiah shared a post on LinkedIn: “The future of precision cancer therapy might be…
Jan 2, 2024, 18:10 |
Insight
Aleix Prat: Excited to unveil our lab's TOP-11 2023 research articles in breast cancer
Aleix Prat, Director of Cancer Institute at Hospital Clinic of Barcelona, shared on LinkedIn: "Excited to…
All:
9
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube